MedTrace Logo

Therapeutic Oxygen for Gastrointestinal Atony (TOGA)

NCT03386136 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-12-12

No results posted yet for this study

Summary

This study is a non invasive study to see if 100% oxygen therapy will help to resolve an intestinal obstruction.

Conditions

  • Ileus
  • Ogilvie Syndrome
  • Small Bowel Obstruction

Interventions

DRUG

100% Oxygen

To provide hospitalized ileus or pseudo-obstruction patient with 100% oxygen via non-rebreather face mask, for 6 hours

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Brian C. Weiner, MD · University of Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-25
Primary Completion
2019-10-17
Completion
2019-10-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03386136 on ClinicalTrials.gov